Insights

Gathering insights about CMM…

Similar companies to CMM

CMM Tech Stack

CMM uses 8 technology products and services including Webpack, Google Workspace, Google Fonts API, and more. Explore CMM's tech stack below.

Webpack
Development
Google Workspace
Email
Google Fonts API
Font Scripts
jQuery
Javascript Libraries
Modernizr
Javascript Libraries
YouTube
Video Players
Google Analytics
Web Analytics
Adobe Fonts
Web Fonts

Media & News

Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology
— New Peer-Reviewed Publication Highlights Phase 2 SPRING Trial Data Supporting the Disease Modifying Potential of Nebokitug in PSC and Supports Advancement to a P hase 3 Registration Trial — TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that the results of its Phase 2 SPRING trial assessing nebokitug in patients with primary sclerosing cholangitis (PSC) were published in the current issue of the American Journal of Gastroenterology.1 The study showed that nebokitug was generally safe and well tolerated in patients with PSC for up to 48 weeks of treatment.
Dec 02, 2025 | www.globenewswire.com
Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit
TEL AVIV, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that co-founder and CEO Adi Mor, PhD, will participate in Oppenheimer's Movers in Rare Disease Summit on Thursday, December 11, 2025, at the Sofitel Hotel in New York City.
Nov 24, 2025 | www.globenewswire.com
Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update
—Nebokitug PSC Phase 3 Design Near Completion Following Positive FDA Feedback— —Regulatory Alignment Advances, with EMA Guidance Supporting a Single Nebokitug Phase 3 Registration Trial Using a Clinical Event Composite Endpoint — —Phase 2 SPRING Trial OLE Data Showing Favorable Safety and Consistent Improvements in Key Biomarkers in PSC Patients Treated with Nebokitug for Up to 48 Weeks Presented at AASLD 2025 — — New Clinical Data Presented at AASLD 2025 Provides Insights on Nebokitug's Direct Macrophage-Mediated Mechanisms that Are Relevant to Halting or Slowing PSC Disease Progression— —Multiple Partnering Options for Supporting the Nebokitug Phase 3 Program Continue to Advance— —Cash Runway Expected through End of Fourth Quarter of 2026— TEL AVIV, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced financial and operating results for the third quarter ended September 30, 2025, and provided a corporate update.
Nov 20, 2025 | www.globenewswire.com
Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis
Chemomab announced three presentations "of distinction" at AASLD The Liver Meeting® 2025 featuring clinical data from the nebokitug Phase 2 trial in PSC.
Nov 06, 2025 | www.globenewswire.com
Best Momentum Stocks to Buy for Oct. 23
PARR, CMMB and GES made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Oct. 23, 2025.
Oct 23, 2025 | www.zacks.com
New Strong Buy Stocks for Oct. 23: MQ, GES and More
MQ, GES, TRV, CMMB and PARR have been added to the Zacks Rank #1 (Strong Buy) List on Oct. 23, 2025.
Oct 23, 2025 | www.zacks.com
Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
TEL AVIV, Israel, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that Chief Executive Officer Dr. Adi Mor will deliver a corporate presentation at the H.C.
Aug 21, 2025 | www.globenewswire.com

CMM's Email Address Formats

CMM uses at least 1 format(s):

CMM Email Formats	Example	Percentage
FLast@cmmpr.com	JDoe@cmmpr.com	40%
First@cmmpr.com	John@cmmpr.com	16%
FirstL@cmmpr.com	JohnD@cmmpr.com	4%
FLast@cmmpr.com	JDoe@cmmpr.com	40%

Frequently Asked Questions

Where is CMM's headquarters located?

CMM's main headquarters is located at 594 Broadway, Suite 500. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is CMM's phone number?

You can contact CMM's main corporate office by phone at

+1-212-979-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CMM's stock symbol?

CMM is a publicly traded company; the company's stock symbol is CMMB.

What is CMM's official website and social media links?

CMM's official website is cmmpr.com and has social profiles on LinkedIn.

How much revenue does CMM generate?

As of December 2025, CMM's annual revenue is estimated to be $1.8M.

What is CMM's SIC code NAICS code?

CMM's SIC code is 7231 - Beauty Shops NAICS code is 32562 - Toilet Preparation Manufacturing.

How many employees does CMM have currently?

As of December 2025, CMM has approximately 320 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Creative Officer (cco)/Evp: C. P.Chief Financial Officer: G. B.President Of Economic Development, Finance And Employment Commission: D. A.. Explore CMM's employee directory with LeadIQ.

What industry does CMM belong to?

CMM operates in the Personal Care Product Manufacturing industry.

What technology does CMM use?

CMM's tech stack includes WebpackGoogle WorkspaceGoogle Fonts APIjQueryModernizrYouTubeGoogle AnalyticsAdobe Fonts.

What is CMM's email format?

CMM's email format typically follows the pattern of FLast@cmmpr.com. Find more CMM email formats with LeadIQ.

When was CMM founded?

CMM was founded in 2005.

CMM

Q: What is CMM's official website and social media links?

CMM's official website is cmmpr.com. CMM has social profiles on LinkedIn.

Q: How many employees does CMM have currently?

CMM has approximately 320 employees.

Q: What technology does CMM use?

CMM's tech stack includes Adobe Fonts, YouTube, Google Workspace, jQuery, Google Fonts API.

Personal Care Product ManufacturingNew York, United States201-500 Employees

CMM is an integrated communications agency specializing in the beauty and lifestyle arenas.  Our full-service PR and Digital Marketing divisions work together to create one voice for your brand, across all platforms – media, events, influencer campaigns, social media and emerging platforms.